Immunogenicity and immunodominant linear B-cell epitopes of a new DNA-based tetravalent vaccine against four major enteroviruses causing hand, foot, and mouth disease., PMID:38705805
Variant enterovirus A71 found in immune-suppressed patient binds to heparan sulfate and exhibits neurotropism in B-cell-depleted mice., PMID:37058406
[Preparation of monoclonal antibody against enterovirus 71 capsid protein VP1]., PMID:35365993
Human Antibodies to VP4 Inhibit Replication of Enteroviruses Across Subgenotypes and Serotypes, and Enhance Host Innate Immunity., PMID:33101238
Structural and functional analysis of protective antibodies targeting the threefold plateau of enterovirus 71., PMID:33067459
Immunization with a fusion protein vaccine candidate generated from truncated peptides of human enterovirus 71 protects mice from lethal enterovirus 71 infections., PMID:32321526
Neutrophil extracellular traps induced by VP1 contribute to pulmonary edema during EV71 infection., PMID:31285854
Determination of the cleavage site of enterovirus 71 VP0 and the effect of this cleavage on viral infectivity and assembly., PMID:31195113
Preparation and identification of chicken egg yolk immunoglobulins against human enterovirus 71 for diagnosis of hand-foot-and-mouth disease., PMID:30831098
Analysis of an Imported Subgenotype C2 Strain of Human Enterovirus 71 in Beijing, China, 2015., PMID:30323801
[Preparation of mouse monoclonal antibodies against EV71 capsid protein VP1]., PMID:30043737
Neutralization Mechanisms of Two Highly Potent Antibodies against Human Enterovirus 71., PMID:29970466
VP1 Amino Acid Residue 145 of Enterovirus 71 Is a Key Residue for Its Receptor Attachment and Resistance to Neutralizing Antibody during Cynomolgus Monkey Infection., PMID:29848582
Non-neutralizing Antibody Responses against VP1 in Enterovirus A, B, C and Rhinovirus A species among Infants and Children in Shanghai., PMID:29615683
Identification and production of mouse scFv to specific epitope of enterovirus-71 virion protein-2 (VP2)., PMID:29356992
Poorly neutralizing polyclonal antibody in vitro against coxsackievirus A16 circulating strains can prevent a lethal challenge in vivo., PMID:29337652
A comparative study of multiple clinical enterovirus 71 isolates and evaluation of cross protection of inactivated vaccine strain FY-23 K-B in vitro., PMID:29073897
Structure, Immunogenicity, and Protective Mechanism of an Engineered Enterovirus 71-Like Particle Vaccine Mimicking 80S Empty Capsid., PMID:29070691
Specific Unbinding Forces Between Mutated Human P-Selectin Glycoprotein Ligand-1 and Viral Protein-1 Measured Using Force Spectroscopy., PMID:29016136
Epitope-associated and specificity-focused features of EV71-neutralizing antibody repertoires from plasmablasts of infected children., PMID:28970483
Effective in vivo therapeutic IgG antibody against VP3 of enterovirus 71 with receptor-competing activity., PMID:28422137
Prediction of Protection against Asian Enterovirus 71 Outbreak Strains by Cross-neutralizing Capacity of Serum from Dutch Donors, The Netherlands., PMID:27533024
[Preparation of monoclonal antibodies against enterovirus type 71 with an epitope-incorporated adenovirus type 3 vector]., PMID:27412945
Vesicular stomatitis virus-based vaccines expressing EV71 virus-like particles elicit strong immune responses and protect newborn mice from lethal challenges., PMID:27373596
Enterovirus 71 transmission by exosomes establishes a productive infection in human neuroblastoma cells., PMID:26837894
Protein microarray-mediated detection of antienterovirus antibodies in serum., PMID:26831405
EV71 virus-like particles produced by co-expression of capsid proteins in yeast cells elicit humoral protective response against EV71 lethal challenge., PMID:26809443
A new EV71 VP3 epitope in norovirus P particle vector displays neutralizing activity and protection in vivo in mice., PMID:26529072
Pros and cons of VP1-specific maternal IgG for the protection of Enterovirus 71 infection., PMID:26529069
Single Neutralizing Monoclonal Antibodies Targeting the VP1 GH Loop of Enterovirus 71 Inhibit both Virus Attachment and Internalization during Viral Entry., PMID:26401034
Development of a Specific Latex Agglutination Test to Detect Antibodies of Enterovirus 71., PMID:26363276
Structures of Coxsackievirus A16 Capsids with Native Antigenicity: Implications for Particle Expansion, Receptor Binding, and Immunogenicity., PMID:26269176
A Broadly Cross-protective Vaccine Presenting the Neighboring Epitopes within the VP1 GH Loop and VP2 EF Loop of Enterovirus 71., PMID:26243660
Monoclonal neutralizing antibodies against EV71 screened from mice immunized with yeast-produced virus-like particles., PMID:26040893
Determinants of EV71 immunogenicity and protection against lethal challenge in a mouse model., PMID:26025091
Characterization of the antibody response against EV71 capsid proteins in Chinese individuals by NEIBM-ELISA., PMID:26023863
Generation and characterization of a protective mouse monoclonal antibody against human enterovirus 71., PMID:25967656
Recombinant adeno-vaccine expressing enterovirus 71-like particles against hand, foot, and mouth disease., PMID:25855976
GITRL as a genetic adjuvant enhances enterovirus 71 VP1 DNA vaccine immunogenicity., PMID:25772201
Cell surface nucleolin facilitates enterovirus 71 binding and infection., PMID:25673703
[Enterotoxigenic Escherichia coli heat-labile enterotoxin B subunit can efficiently induce and enhance the mucosal immune response to enterovirus 71]., PMID:25481175
The enterovirus 71 procapsid binds neutralizing antibodies and rescues virus infection in vitro., PMID:25428877
[Effects of pH on the properties of colloidal gold labeling monoclonal antibody]., PMID:25374082
[Expression and activity determination of recombinant capsid protein VP2 gene of enterovirus type 71]., PMID:24969459
Identification of specific antigenic epitope at N-terminal segment of enterovirus 71 (EV-71) VP1 protein and characterization of its use in recombinant form for early diagnosis of EV-71 infection., PMID:24952304
Oral immunization with recombinant enterovirus 71 VP1 formulated with chitosan protects mice against lethal challenge., PMID:24885121
Recombinant tandem multi-linear neutralizing epitopes of human enterovirus 71 elicited protective immunity in mice., PMID:24885030
A novel universal neutralizing monoclonal antibody against enterovirus 71 that targets the highly conserved "knob" region of VP3 protein., PMID:24875055
Expression of enterovirus 71 capsid protein VP1 in Escherichia coli and its clinical application., PMID:24688514
Epidemiology and seroepidemiology of human enterovirus 71 among Thai populations., PMID:24548776
For research use only. Not for human or drug use.
